This inventor holds 1 USPTO granted patent. Top assignee: University of Michigan. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Emmanuelle Charafe-Jauffret: Innovator in Cancer Research
Introduction
Emmanuelle Charafe-Jauffret is a prominent inventor based in Marseille, France. She has made significant contributions to the field of cancer research, particularly in the identification and treatment of cancer stem cells. Her work has implications for the diagnosis and characterization of solid tumors.
Latest Patents
Charafe-Jauffret holds a patent for "Aldehyde dehydrogenase 1 (ALDH1) as a cancer stem cell marker." This invention relates to compositions and methods for treating, characterizing, and diagnosing cancer. The novel stem cell cancer marker, ALDH1, is particularly useful for the diagnosis, characterization, and treatment of solid tumor stem cells. She has 1 patent to her name.
Career Highlights
Emmanuelle Charafe-Jauffret is affiliated with the University of Michigan, where she continues her research in cancer biology. Her work has garnered attention for its potential to improve cancer treatment outcomes.
Collaborations
Charafe-Jauffret has collaborated with notable researchers in her field, including Max S Wicha and Gabriela Dontu. These collaborations have furthered the understanding of cancer stem cells and their role in tumor development.
Conclusion
Emmanuelle Charafe-Jauffret is a key figure in cancer research, with her innovative work on ALDH1 paving the way for advancements in cancer diagnosis and treatment. Her contributions are vital to the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile